| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $390.7M+37.2% | $284.9M+25.8% | $226.5M-32.9% | $337.6M+1.7% | $331.9M |
| Cost of revenue | $159.4M+41.7% | $112.5M+25.5% | $89.7M-30.3% | $128.7M+4.0% | $123.7M |
| Gross profit | $231.3M+34.2% | $172.3M+26.0% | $136.8M-34.5% | $208.9M+0.4% | $208.1M |
| Research and development | $238.5M+5.5% | $226.1M+5.1% | $215.1M+4.9% | $204.9M+22.5% | $167.3M |
| Selling, general and administrative | $75.3M+3.4% | $72.8M-4.6% | $76.3M-2.5% | $78.2M+11.1% | $70.4M |
| Total operating expenses | $313.8M+5.0% | $298.9M+2.6% | $291.4M+2.9% | $283.2M+19.1% | $237.8M |
| Loss from operations | -$82.5M+34.8% | -$126.6M+18.1% | -$154.6M-108.1% | -$74.3M-150.5% | -$29.6M |
| Other income, net | $8.8M-0.4% | $8.9M+47.0% | $6.0M+81.7% | $3.3M+231.1% | $1.0M |
| Loss before income taxes | -$73.7M+37.4% | -$117.7M+20.7% | -$148.5M-109.4% | -$70.9M-147.7% | -$28.6M |
| Provision (benefit) for income taxes | $2.2M+460.1% | -$602K-102.9% | $20.9M+476.2% | -$5.6M-149.0% | -$2.2M |
| Net loss | -$75.9M+35.2% | -$117.1M+30.9% | -$169.4M-159.1% | -$65.4M-147.6% | -$26.4M |
| Basic | $42.70B+3.4% | $41.30B+3.6% | $39.88B+3.9% | $38.36B+4.9% | $36.58B |
| Diluted | $42.70B+3.4% | $41.30B+3.6% | $39.88B+3.9% | $38.36B+4.9% | $36.58B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.